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A B S T R A C T
T he gl yoxa l ase pa t hwa y funct io ns t o de t o xif y r e ac t ive d ica r bo nyl co mpo und s, mo st imp or t a nt l y me t hyl gl yoxa l .
T he g lyo xal a se pa t hwa y is a n a ntio xid ant d e fe nse me c ha nism t ha t is esse nt ial fo r ne uro pr o te c t io n. E xc e ssive
c onc ent r a tio ns o f me t hylg lyo xa l h ave d e l et e r ious e ec t s o n ce l ls, l e ad ing t o inc re a se d le ve ls of in a mmat io n a ndff fl
o xida t ive str e ss. Ne ur od e ge ne ra t ive dise a se s incl uding Al zh eime r 's, P a rkinso n's, Ag ing and Aut ism Sp ec t rum–
D isor d er ar e oft e n ind uc ed o r e xa ce r ba t ed by a cc umul a tio n of me t hylg l yoxa l. Ant io xid a nt c omp ound s po sse ss–
se ve ra l d ist inct mec ha nisms t ha t e nh anc e t he g lyo xal a se p at h wa y a nd f unc t ion a s ne ur op ro t e ct a nt s. Fl a vo noid s
a r e we ll - re se a rc he d se c ond ar y pl a nt me t a bo lit e s t ha t ap pe a r t o be e e ct ive in re d ucing le ve ls o f o xid a t ive str e ssff
a nd in a mma t ion in neur a l c el l s. No ve l avo noid s c o ul d be d e signe d , synt he size d a nd t e st e d t o p ro t e ct a ga instfl fl
ne uro d e ge ne ra t ive d isea se s th ro ugh r e gul a t ing t he g l yo xa la se p a t hwa y.
1. Introduction
Th e g yloxal as e pathway i s a wel l- conse rved antioxi dant de fe nse
syste m found in all ce lls of th e body . Th e g lyoxal as e pathway[ 1 4]–
faci li tate s th e ne utrali zation of h i gh ly re ac ti ve and oxi di zi ng dic arb on yl
mol ec ule s, wi th me thyl gl yoxal (MG ) be i ng th e mos t cri ti cal targe t .[5]
Carb on yl mole cu le s targe t th e brai n due to i ts hi g h rate of metabol ism
and l ow anti oxi dant defe ns e capac ity . Th e b rai n also c on tai ns h ig h[ 6]
conce ntrati ons of oxidi zabl e sub strate s i nc ludi ng polyuns aturate d fats
and me tal i on s . A ccumul ati on of M G damag es and i n u en ces th e[ 7] fl
ce llu lar e nvironme nt, l eadi ng to a state of ch roni c in ammati on an dfl
oxi dative stre ss . The g lyoxalase syste m i s pres en t i n all ce ll s[4, 5,8 12]–
i n th e b ody, but h as e spe ci al ly i mportant func tions in th e b rai n [ 3,13].
Oxidati ve stres s (OS) resu lts f rom an imb al an ce be twee n el ec tro-
phi li c prooxidati ve mole cu le s and the capaci ty of antioxi dan ts to re duce
and ne utrali ze th e fre e radic al s . It i s a c hroni c s tate of i n-[ 14]
flammati on th at pre ve nts th e prope r func ti on of i nteg ral c el lul ar pro-
ce sse s, causi ng i rre ve rsi b le damag e to ce ll s . E xc es si ve oxi -[ 10,14,15]
dati ve stre ss in the b rai n le ads to acce le rate d ag in g, and i mpacts the
se veri ty of ne urodeg e nerati ve di se as es . Hi g h l eve ls of oxi dati ve[ 16,17]
stre ss in ue nce the onse t an d progre ssi on of ag i ng, Alzh e ime r's di se asefl
(AD), Parki nson's di se ase (PD), and auti sm s pe ctrum di sorde r (AS D)
[18, 19] . Effici e nt an d acti ve fu ncti on of th e g lyoxalase pathway i s
cri ti cal to re duci ng oxi dati ve stre ss medi ate d damag e to b rai n ce lls
[20 24]– . F lavonoid antioxi dant compounds poss es s th e c apaci ty to
en hance th e g lyoxalase path way throug h se veral di sti nct me ch ani sms,
in cludi ng modul ati on of cri ti cal si g nali ng path ways i nvolve d i n ce ll
proli fe rati on [ 25 27] .–
OS and in ammati on g radu al ly in crease durin g agi ng .fl [28,29]
Howe ve r, h i gh le vel s of OS and i n ammati on can acc rue ove r ti me andfl
are c on tri bu ting factors to agi ng and ne urode g en erative di se ase s in-
cludi ng A D, PD, A SD, de me ntia, and psyc hi atri c di sorde rs .[ 1,30]
Hall marks of th es e di se ase s are als o s hare d in g lyoxalase path way
dysfunc ti on: in crease d re acti ve oxyg en spe cie s (ROS ) produ cti on,
apoptos is , and oxidati on of mole cule s . The onse t and pro-[2, 9, 31,32]
gre ssi on of ne urode ge ne rati ve di se ase can be i n u enc ed b y sub sti tue ntsfl
of the g lyoxalase path way. F or e xample , inh i bi ti on of g lo 1 re duce s
ne uron al vi ab i li ty and i ncre ases accumul ati on of advance d g lyc ati on
en dproducts (AG Es), wh il e ove re xpre ssi on of g lo 1 redu ce s formation of
ROS . Ag in g is correl ate d wi th a dec rease i n g l o 1 con-[ 4,21,33,34]
ce ntrati on and acti vity . De ple tion of GS H by MG can pre vent[16,35]
as trocyti c de toxi cati on of re acti ve mole cu le s and le ad to an inc rease i nfi
oxi di zed prote in s, l i pi ds, and ami no ac ids . Incre asi ng the c a-[21, 36]
paci ty and e ffi ci en cy of th e gl yoxalase pathway appears to b e an
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e ec ti ve me an s of re duci ng th e on se t an d se veri ty of ag in g and ne u-ff
rode g e nerati ve di se ase [ 37] .
1.1. Glyoxalase pathway
Th e g lyoxalase path way cons is ts of prote in s g lyoxal as e 1 (g lo 1) an d
g lyoxalase 2 (g lo 2), re duce d gl utath i one (G SH ), and a di carb onyl
sub strate ( ) . The pathway i s a se ri e s of two re acti onsF i g . 1 [ 4,16, 21]
that ne utral ize MG to produc e D- lactate . MG spon tane ousl y re acts with
GS H to form a h e mith ioace tal . I t i s catalyze d by gl o 1 i nto an i nter-
medi ate compound S, D- lactylg lu tath ione . Gl o 2 catalyze s th e nal re -fi
action produc ing D- lactate an d rec ycli ng G SH i nto th e path way .[21]  
Th e rate of g lyoxal as e ac tivi ty varie s base d on th e type , location, an d
e nvironme nt of th e cel l . Th e g lyoxal as e path way i s a dy-[ 30,38,39]
nami c syste m able to re spond to th e constantly c hang i ng ce llul ar e n-
vironme nt. Th e gl yoxalase path way i s i n eve ry ce ll , and is i mpli cate d i n
cance r c el l proli ferati on , mai nte nan ce of b lood g lucose , li ve r e nzyme s,
and cardiovascu lar an d re nal fu ncti on [40] .
MG i s a b yproduct of gl ycolysi s and th e me tab oli sm of prote i ns and
li pids MG i s an el ectrophi le and hi g hl y reacti ve g lycatin g ag e nt,[ 5].
able to i rreve rsi bl y modify protei ns , li pi ds, and nucl ei c aci ds, formin g
advanc ed g lyc ati on e nd products (AG Es) . S tructural modi c a-[ 5,10] fi
tions to mole cule s can si g ni can tl y re duce fu nction, and may l ead tofi
deg radati on b y i mmu ne ce ll s . MG i s s tab le mole cul e, and me m-[ 41]
brane pe rme abl e in ce rtai n f orms. Exce ss MG i s ab le to le ak i nto s ur-
roundi ng c el ls and ti ss ue s . In a functi oni ng g lyoxalase s ystem, MG[42]
i s de grade d and preve nte d from ac cumul ati ng . Un der a s tate of[ 21]
dysfunc tion - c au se d b y damage to pathway consti tu en ts , hi g h le ve ls of
metaboli sm, or h i gh le ve ls of carb onyl pre cu rs ors pre se nt - MG wi ll be
produc ed at a hi g he r l eve l and di srupt macromol ec ular functi ons .[58]
Acc umulati on of MG has many del ete ri ou s e e cts th at le ad to a ce llu larff
e nvironme nt wi th h i gh le vel s of in ammation and oxi dati ve stre ss (OS)fl
[ 4] .
MG i s dire ctly ab le to c aus e impairme nt to the gl yoxalase sys te m
[ 5] . ROS can be di rec tly produc ed duri ng i ts formati on and de g radati on
[ 43 45]– . M G c an als o de ple te th e conce ntration of anti oxi dant enzyme s
[ 46] . MG i s also ab le to modulate important si gnali ng pathways, re-
sul ting i n exce ss ive ROS , i n ammati on, apoptosi s, and ulti mate lyfl
ch roni c oxi dative s tre ss , l eadi ng to de ath of brain ce ll s, tis sue s, and
di sease [ 5] .
MG can neu trali ze e nzymes that are ab le to catal yze reacti ons and
scave nge sub strate s, i ncl udi ng G SH . MG can also i n-[ 1,5,39,40,42]
cre as e NADPH oxi dase activi ty, preve nti ng the re ducti on of GS H an d i t's
rec ycli ng b ack i nto the g lyoxalase path way . G SH pro-[1, 6, 39,40,42]
tec ts ag ai nst OS b y dire ctly scave ngi ng ROS, and re gul ate s redox
si gnal ing It al so plays a vi tal rol e i n DNA and protei n re pai r and[ 6,43].
synthe si s, me tal i on me tab ol i sm, an d c el lular survi val . I t i s one[36, 47]
of the most i mportant e ndoge nous anti oxidants, and prope r l eve ls are
paramou nt to a ce ll 's h ealth and normal fu ncti on in g.
2. Diseases of glyoxalase pathway
I mpai red func ti on of the gl yoxalase pathway e spe ci al ly in th e–
brai n - has very se ri ous rami fications for ce lls and tis sue . Ag ing ,
Alzh e ime r's, and Park ins on 's, ( ) are ne urode ge ne rati ve di se as esF i g . 2
that can b e cause d or i n u enc ed by e le vated l eve ls of oxidati ve stres sfl
[4, 48, 49]. Th e se di se ase s are comple x and mu lti fac tori al, and can be a
cause and c on seq uen ce of di srupted gl yoxalase pathway fu ncti on. In -
crease d le ve ls of oxi dati ve stre ss can b e a res ult of gl yoxalase s ystem
impairme nt Psych i atri c di sorde rs l ik e A SD, sch i zoph reni a,[ 19, 50,51].
an xi e ty, b ipolar di sorder, an d depre ssi on c an al so be a caus e/ e ec t offf
impaire d g lyoxalase func tion Th e g lyoxlase path way e xe rts[52 54] .–
control over anti oxidant de fe nse me chani sms th at are paramoun t for
home os tasi s of the re dox e nvironme nt of th e ce ll Di srupte d[55,56] .
functi on of th e g lyoxal as e path way c an le ad to an i n ammatory e n-fl
vironme nt contri buti ng to th e path og e ne si s of n eu rode g ene rative di s-
ease . MG can cause mutati ons of DNA and nuc le ic aci ds, cul-[ 23,40]
mi nati ng i n tel ome re sh orte ni ng, loss of h e teroch romati n, alte red g en e
expres si on patte rns, and mi toch ondri al dysfunc ti on [ 23,57,58] .
Oxi dati ve stre ss re sul ts from the di se qui li b ri um be twe e n l eve ls of
prooxidant mol e cule s produ ce d and th e ab i li ty of a bi ologi cal sys tem to
detoxi fy and ne utrali ze th e re ac ti ve mole cul es OS i s a c hroni c,[14] .
se lf- pe rpetu ati ng state of damag e to ce ll s and i nc re ase d i n ammati onfl
res ulti ng from the corre spondi ng i mmune response . G lyoxalase[ 27, 43]
path way dysfun ction can res ult i n th e acc umulati on of M G i n cel ls .[ 3]
The b ui ld up of MG h as a di re ct l in k to th e propag ation of OS an d
in ammati on , and i s an i n ue nc ing factor i n neu rode g ene rative di seasefl fl
[8, 23, 48].
Th e mai n source of damage from OS i s ROS me di ate d i n ammati onfl
[43] . ROS and fre e radic al s h ave u npai re d e le ctron s, and ac t as nu -
cle oph i le s to attac k mac romole cul es . Th e don or mol ec ule gi ve s i ts
el ec trons to ROS . Th e mole cul es attacke d b y ROS have structural[ 14]
modi cations, whi ch caus es the mole cule s to h ave li mi te d or no func-fi
tion . U nde r normal condi ti ons, ROS are us ed in ce ll si gnali ng and[ 5]
defe nse agai nst pathog ens by macrophag es ; th ei r damag i ng e ects areff
cause d wh en the y have accumul ate d pas t a normal amou nt [10] .
Gl yoxalase c yc le dysfu ncti on i s one pe rpe trator to blame for th e i n-
crease d ROS producti on.
A GE s can b e f orme d from modi ed prote i ns, l ipi ds, or nucl ei c aci dsfi
[59] . Struc tu ral ch ang es can redu ce b iol og i cal ac ti vi ty of
Fig. 1. The gl y ox a l a se pa t hw a y fu nc t io ns t o det ox i fy m et hy l -
g l yo x al . Met hy l gl y ox a l rea c ts w it h r edu ced g l ut a t hio ne (G SH ) t o
fo rm a hem it hio a cet a l (H TA ). G l o 1 u ses the hem it hioa c et a l a s a
s ubs t ra t e t o fo rm S,D -l a c t y lg l u ta t hio ne. Gl o -2 rea c ts w it h t he re-
s ul t in g int er med ia t e c om po un d, a n d t he p at hw a y pro du c es D -
l a c t at e. Thi s st ep a l so red uc es g lu t a t hi on e a nd r ecy c l es it in t o t he
pa t hw ay .
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mac romole cul es , and are ofte n i de nti e d as mi sfolde d or damag ed andfi
labe le d for de struc ti on . N ucl ei c aci d (and mtDN A) can unde rgo[ 59, 60]
strand bre aks, impaire d re pai r me chani sms, and permane nt mu tati ons
[ 61] . Li pids are e asi ly oxi dizabl e , and me mb ran es , be i ng ri ch in l ipi ds,
are prone to th es e modi c ati onsfi [ 43] .
Re se arc h has s hown a l in k b etwe en MG accu mu lation, gl yoxalase
syste m activi ty, and dis ease . G lyoxal as e ac ti vi ty i s di e ren ti all y[ 21] ff
e xpre sse d base d on ce ll type and s tate . Gl yoxalase activi ty has found to
i ncre as e wi th age , bu t sub je cts ove r 50 ye ars old exh ib i t a de cli ne i n
g lyoxalase I . Th e low g lo 1 activi ty in ag in g le ads to a hi g he r le vel[ 62]
of di carbonyl compounds , and i t was al so di scovere d th at decre asi ng
g lo 1 le ve ls corre late d wi th an ac cumulati on of A GEs Ele vate d[ 35] .
le vel s of MG le ads to i n ammati on, OS , apoptosi s, and DNA damag efl
[ 40, 63] .
It has be e n sh own th e path ol ogi cal hall marks of A D an d PD are
colocali ze d to A GEs . I n a compari son of gl yoxalase acti vity[41, 63, 64]
be twee n h ealth y and AD b rai n ti ssue , th e AD g roup h ad a si gn i cantlyfi
lowere d g lo 1 activi ty, at th e mRNA and protei n le ve l [35] .
MG i s hi g hl y re ac ti ve and als o cytotoxi c. MG i nhi b its ce ll g rowth ,
and i nduce s ce ll death at hi g he r c onc entrati ons . MG pre ve nte d[ 65]
prope r hi ppoc ampal ne urog en es is, adve rse ly i mpacti ng ne ural di e r-ff
e ntiati on , survi val, and prol i ferati on, i t i s b e li eve d due to re duce d
hi ppoc ampal BDNF le vel s . MG conce ntrati on can act as a b i o-[66]
marke r of se veri ty of di se ase A D pati en ts we re found to have[ 23] .
i ncre as ed M G i n C SF compare d to he alth y ag ed control s [ 64] .
3. Aging
A gi ng is a prog re ssi ve de cl ine i n ph ysi olog ic al and me tab ol i c
func ti ons of an org an is m Th e proce ss i s ch aracte rize d by ch ronic ,[ 10].
low le vel i n ammation th at prog re sse s ove r ti me . Th e rate of agi ng canfl
be acc el erated and i n ue nce d b y g e neti c an d en vi ronme ntal factors .fl
Ag e i s also th e b i gg e st ris k factor for A lzh ei me r's and Parki nson's .[ 19]
Ag e i s corre late d wi th an i ncre ase i n ROS formati on, oxi dize d prote in s
and li pi ds, and apoptos is . Al so, du ri ng n ormal ag i ng OS wi ll i n-[ 14]
cre as e whi l e g lutathi one activi ty decre ase s. Dec re asi ng g lo 1 le ve ls are
strongl y corre late d wi th i ncreasi ng le vel s of AG Es, an d gl o 1 le vel s drop
i n accordan ce to age [ 16] .
Th e e xten t of damag es c an only b e vi e we d posth umousl y, requ iri ng
the de termi nati on of di se as e prog ress ion throug h b iomark ers of oxi-
dati ve s tre ss and di se ase . Marke rs den oti ng oxi di zed su bstrates , nucl ear
ab normal iti e s are di re ctly rel ate d to the exte nt and prog res si on of ag i ng
[15] .
4. Alzheimer's disease
A lzh ei me r's dis ease i s the most c ommon ne urodeg e nerati ve dis -
orde r, and the l eadi ng cause of de me ntia i n th e e lde rly I t is a[ 67] .
mu lti fac tori al di se ase ch aracte ri zed by progre ssi ve ne ural loss of the
hi ppocampus and corte x, me mory and le arni ng impairme nt, and
ch ang e s i n be havi or an d personali ty . I t has path oge ni c h all-[ 19,68]
marks of b eta amyl oid (A ) plaque s and ne uro b ril lary tang le s (NF T)β fi
[69] . Cog ni ti ve i mpai rme nt refle cts synaps e loss i n de ntate gyrus of
hi ppocampus, and ne uron loss i n frontal and pari e tal lob e of cortex
[70 72] .–
Th e amyloid pre curs or prote i n (A PP) is a me mbrane prote i n th ou gh t
to be in vol ve d i n pl as tic ity, synapse formati on and repair, and export of
me tal i ons The A PP pre se nt i n th e brai n can be c le ave d b y th ree[ 68] .
di ere nt se cre tas es . Cl eavag e of APP rst b y alph a sec retaseff [ 73, 74] fi
an d the n gamma- se cre tase re sul ts i n a functi onal prote i n; whi le c le a-
vag e b y b eta- se cretase re sul ts i n A . Th e produ ct forme d from th isβ
imprope r cl eavage b eta amyloi d - wil l ag gre g ate i nto plaque s, and–
dis rupt func ti on of normal c el ls . The se A plaque s can b e[ 19,74] β
modi ed b y M G and AG Es, forming crossl ink s, a ordi ng the m s tab il i tyfi ff
an d de fens e agai nst protease cle avag e [ 75,76]. Aβ plaque s are ve ry
stable and h ave l ong li ve s - Th e progre ssi on of A D i s prec ede d 15 ye ars
by appearance of A deposi ts A pl aqu es wil l di srupt ne uronβ [ 23, 41]. β
functi on, and i ndu ce ROS produ ction, ulti mate ly le adi ng to i n amma-fl
tion, damag e to ce ll/ ti ssue , an d apoptos is [48, 69, 77, 78].
A ag g reg ates wi ll clump around neu rons and pre ven t th ei r properβ
functi on . Th e A plaque s als o attrac t and activate mi crog li a,[ 67] β
causi ng th e m to clus te r an d l oc al ize arou nd th e plaque s . The se[ 21,67]
immune c el ls rel ease s ig nals i nduci ng c el lul ar toxi ci ty . Th e A[ 68] β
pl aq ue s caus e addi ti on al produ ction of AG Es, wh i ch wil l re duce th e
ac ti vi ty of en zyme s and prote in s (e spe ci al ly i n mi tochondri a) .[41]
The se AG Es wi ll le ad to i ncre as ed ROS produ ction, wh i ch i ncre ases th e
produc ti on of APP [23,68] . Aβ pl aqu es c an als o di srupt redox si gnal ing
by i nteracti ng wi th me tal ions i n acti ve si te s of macromol ec ule ,
Fig. 2. Met hy lg l y ox a l is a hig hly rea c ti ve co m pou nd w it h m a ny d elet er iou s e ec t s on n euro ns . MG m edi at es t he in c rea sed pr odu c t ion o f RO S, f ree r ad ic a ls , p ro-i n a m m at o ry c y t okin es,ff fl
a nd a d va n ced g ly c a t ion end p rod uc t s , ha s da m ag in g e ec t s on m it oc hon dri a f un ct i on a n d n uc l eic a ci ds , an d in c rea ses ap opt o sis t hro ug h mu l t ipl e m ean s , i nc l ud in g s ign a li ng pat hw a yff
a ct iv a t io n. The resu l t in g inc r eas e in o xi da t iv e s t res s a nd in a m m a t ion pl ay s a m a jo r ro l e in a gin g a nd d ev el o pm ent of n eur od egen era t ive d isea s e i nc l ud in g Al z heim er's , Pa r kins on 's,fl
Au t is m S pec tr um D iso rd er, a nd H u nt in gt o n's .
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pre ve ntin g proper func ti on [ 48] .
Impairme nt of th e g lyoxalase syste m can have a di rec t i mpact on the
se veri ty of A D . Studi e s have s hown g lyoxal as e I le ve ls de cre as e[ 22,73]
with i ncre ase d agi ng and se veri ty of A D . Th e imb al an ce of anti-[ 14]
oxi dant a e cts caus es a sh ift to a state of OS . Acc umulation of MG andff
AG Es in the A lzh ei me r's di se as e brai n i s ve ry de le te rious Ti ssu e[ 75].
from AD b rai n s hows h i gh amounts of AG Es and oxi di zed li pi ds and
prote i ns, wh ich i s a marke r of in ammati on . Th ere i s a c orre lationfl [ 41]
with th e amount of MG /A GEs locali ze d to spe ci c brai n re gi ons an dfi
se veri ty of AD [ 75] .
NF T are lame nts of b undle d prote i ns forme d from a di sruption i nfi
the mi crotu bul e ne twork of cel ls . Mi crotu bul e associ ate d pro-[ 67, 74]
tei n tau i s re spon si ble for promoti ng and s tab il izi ng mi crotubu le for-
mati on i n ce lls, h owe ve r hype rph osphorylation of tau des tab il ize s and
di srupts the prope r as se mb ly of mi crotu bul es . Protei ns ag -[79,80]
g re g ate and oli g ome ri ze formi ng toxi c NF T, c au si ng th e de ath of ne u-
rons i n the area [ 81].
In crease d MG le vel s, apoptosi s, and OS c on tri bu te to produc tion of
A and hype rph osph orylation of tau . M G can also di srupt ce ll si g-β [5]
nali ng pathways that control ki nase s and ph os ph atas es u sed to reg ul ate
phosph oryl ati on of tau A has an i n ue nti al and contrib uti ng[1, 59] . β fl
role i n th e producti on of N FT, and th ey are both s tab le mole cu le s prone
to g lyc ati on MG de rive d AG Es ag gre gate in NF T and b eta amyl oi d[76] .
plaque s . AG E crossl i nki ng i n A a ords i t i nsol ubi li ty and prote ase[ 19] β ff
res is tanc e . MG modi e d A i n plaque s h as a l onge r h alf- li fe ,[75, 76] fi β
allowi ng i t to accumul ate more AG E modi cations , wh i ch c au ses morefi
A to formβ [9, 67] .
5. Parkinson's disease (PD)
Parki nson's is the s econd common ne urode g en erati ve di se ase . I t i s
ch aracte rize d b y de g en eration of dopami ne produc in g neu ron s i n th e
sub stantia n ig ra Thi s le ads to a de crease of dopamine l eve ls i n[ 19] .
are as of th e b rai n associ ated wi th move men t, cause d by de re gu lati on i n
g ang li on c el l ci rcu its . T he di se ase is ch aracte ri zed by motor[81 88]–
de ci e nci e s - i nclu din g tre mors , ri gi di ty, and sl own ess of move me ntfi –
and c og ni tive de ci e nci e s . Path ol og i cal marke rs of Parki nson'sfi [ 49]
i nclu de the accumul ati on of alph a synu cle i n i nto Le wy b odie s [ 57, 84] .
Th e de ge ne rati on of dopami nerg i c ne urons and oxidati on of dopami ne
cause s alte re d mitoch ondrial res pi rati on, i nduci ng a state of oxi dative
stre ss i n ne ural ti ssue [ 49,89] .
A lpha synuc le in (AS ) i s a prote i n locate d i n pres ynapti c termi nals of
ne urons th at functi ons in re cycli ng and storag e of ne urotrans mi tte rs
[ 17] . Un der c on diti ons of i n ammation and oxi dative stre ss, AS pro-fl
tei ns mi sf ol d and accu mu late i nto ag g re g ate s . The ag gre g ate s[81, 90]
of mi sfolde d A S ol ig i mori ze i nto Le wy bodi e s. The se ag g re g ate s are
cytotoxi c, di srupt conne cti on s b etwe e n ne urons, and de ple te le vel s of
ne urotransmi tters . AS als o re ac ts wi th dopami ne qui none s le adi ng[ 81]
to accumul ati on of toxi c b ri ls in th e dopamin erg i c ne uronsfi
[ 80, 89, 90]. Ac cumulati on of A S and Le wy b odie s have a de tri men tal
i mpact on mi toc hondri a ac ti vi ty, c au si ng an el evati on of ROS produc-
tion and de cit in me taboli c acti vi tyfi [57] .
Ne ural dopamine can b e come oxi di ze d i f the re are h i gh le vel s of M G
deri ve d A GEs The se dopami ne qu in one s have i mpai red ac ti vi ty,[49] .
and contrib ute to the de ge ne rati on of ne urons . MG accumul a-[ 18,90]
tion can le ad to producti on of ROS and de ple ti on of N ADPH, whi ch i s
cri tic al for re du ci ng gl utath i on e for use i n th e g lyoxalase path way
[ 81, 91, 92]. T he dec li ne i n s ynthe si s of dopamin e also caus es di srupti on
i n ve si cle transport, and make s th e ce ll prone to damag e an d mtDNA
mutati ons [ 84] .
Th e re i s a c orre lation be twee n prog res si on of di sease and b i o-
marke rs of oxi dative s tre ss . Post morte m studi e s of PD b rains[93, 94]
sh ow hi g h l eve ls of oxidi ze d sub strate s, and colocal izati on of AG Es to
Le wy bodi es . AD and PD h ave di ere nt cl in ical path ologi e s but[ 89] ff
sh are si mi lar caus es and symptoms an d A pl aqu es can b e commonl yβ
found i n PD brain s Pati e nts wi th PD have b ee n f ou nd to h ave[ 19].
deple te d le ve ls of GS H, and di sruption of G SH metaboli sm has be en
found to prog re ss ne urologi cal dis orde rs [ 36].
6. Autism spectrum disorder
A uti sm Spe ctrum Dis orde r i s a mu ltif actori al ne urode ve lopmen tal
dis orde r cate gori zed b y i mpai rme nt i n communi cation, l an gu ag e , s oc ial
be havi ors and re lati on shi ps . Th e b as is for A SD i s s til l mi sun de r-[24]
stood, b ut th ere i s evi de nce of ce ll ular and me taboli c dys functi on i n-
flue nce d b y mi toc hondri al acti vi ty . The re are al so ph ysi cal ab-[ 95]
normali ti es and alte rati ons i n ASD b rai ns. Ove r 100 g en es c ontri bu te to
AS D, mutati ons in any of the se c an le ad to AS D . Al l g e ne s parti -[ 20]
ci pate i n di  ere nt brai n func ti ons controlle d b y th e b rai n are as, whi chff
a ect emotional formati on, l e arni ng and me mory, cog ni tive control ,ff
an d soci al ori e ntati on [ 96].
A uti stic b rains als o have a lowere d le vel of vi abl e G ABA produci ng
Purki nje ne uron ce ll s . MG deri ve d AG Es and ROS wil l modi fy the[ 97]
Purki nje ne urons, l eadi ng to th e ir ulti mate death The OS e x-[ 98] .
hi b ite d in AS D can b e a cause of loss of the se i nteg ral ne uron ce lls .[ 53]
Combi ne d wi th th e h ig h amou nts of li pi d peroxi dati on, th e OS ex-
hi b ite d in ASD brai ns could be al le vi ated by g lyoxalase de pen de nt MG
detoxi cati onfi [ 99,100].
DNA and mtDNA mutati ons and ab normali ti es are common i n A SD
[97, 101] . Th es e can cause i mpai red e le ctron transport ch ai n (ETC) and
mi toch on dri a functi on (memb rane pote nti al /polari zati on, mole cu le
trans port, mito prote i n transl oc ati on, and apoptosi s) A SD i s[ 102, 103] .
al so cate gori zed by an abnormal i mmu ne res pons e; thi s can h ave ne-
gati ve e e cts on brain growth fac tors, de vel opme nt, and ne ural trans-ff
mi tte rs . Pati e nts wi th au tism de monstrate d acti vate d mi cro/[ 52, 104]
as tro g li a and i ncre ased le vel s of proapoptoti c cytoki ne s Pati e nts[ 52].
of AS D h ad sig ni cantly l owe r rati os of mi toc hondri a prote ins b cl- 2/fi
bak, whi ch i s an i ndi cator of in crease d ce ll de ath and de crease d func-
tion [ 24] .
A bnormal ne ural brain maturati on found i n ASD i s in ue nce d b yfl
mi toch on dri a dys functi on and MG me diate d ce ll ular sig nali ng
[97, 101] . ASD can l ead to c hroni c immune acti vati on, causi ng OS i n th e
AS D brain . The se can be caus ed by di se qui li b riu m in MG and[ 101]
gl yoxalase s ig nali ng . Pati e nts wi th au tis m have lowe r reduc ed[ 105]
gl utath i one le vel s, howe ver it i s not known if i t i s due to a de ci t i nfi
synthe si s or re ge ne rati on of g lutathi one [ 100] .
7. Flavonoid function
A nti oxi dants are compounds - whe n pre se nt at a l owe r conc entra-
tion compare d oxi dizab le s ubs trate - that del ay or pre vent oxidati on of
the su bstrate . Anti oxi dants act as nuc le oph il es to re duce an[14, 106]
oxi dative mole cu le to preve nt its i nteracti on wi th anoth e r mol ec ule
[14, 107] . Endoge nous antioxi dan ts produ ced by the b ody func ti on i n
pre ve ntion and ne utral izati on of ROS and free radi cals, re pai r of da-
mag e d macromol ec ule s, and re dox s ig nali ng . Exoge nous anti-[ 14]
oxi dants consume d th rough food and drink al so play an i mportant rol e
in ce llu lar de fen se and survi val, an d have sh own to ai d the b ody i n
comb ating oxi dati ve stre ss and in ammati onfl [108,109] .
F lavonoids are se condary pl an t me taboli tes commonly f ou nd in
frui ts and ve g etabl es . F lavon oi ds are a f ami ly of pol yph e nol an-[ 25]
tioxi dants that are e ec ti ve i n c omb ati ng h i gh le ve ls of OS .ff [ 10,14]
Fl avonoi ds are di sti ng ui sh ed by th e pre se nce of mul ti ple phe nol ri ng s, C
to C dou ble b onds, and hydroxyl g roups . Th es e structural c har-[ 26]
ac te ri sti cs confe r th e anti oxi dant fu ncti on of avonoi ds, and thefl
numbe r and l ocati on of hydroxyl g roups i n u enc e th e b iolog i cal ac-fl
tivi ty of th e avonoids . The l ipophi li ci ty i s al so i n u en cedfl [ 106, 110] fl
by s tru cture, wh ic h al lows s ome avonoi ds to favorab ly pass th roug hfl 
the blood brai n b arri e r The hydroxyl g rou ps are c ri ti cal for[111 114] .–
an ti oxidant acti vi ty, and scave nge fre e radi cals and ROS by donati on of
a proton [114] .
Th i s c lass of anti oxi dant mol ec ule s posse sse s seve ral di sti nct
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mec hani sms of prote cti on from oxi dative stre ss. F lavonoids can dire ctly
scave nge and neu tral ize ROS an d fre e radi cals, i ncre ase i ntrace ll ular
GS H, preve nt g lutamate me diate d Ca i n u x, and modu lation of si g -fl
nali ng path ways i nvolve d i n c el lul ar survi val Di rec tl y ne u-[ 4,25,26] .
tral izi ng ROS pre ve nts th e oxi dati on of prote ins , ami no acids , l ipi ds,
metal i ons , and othe r macromol ec ule s. Oxi dati ve modi cati on i rre-fi
vers ib ly ch ang es s tru cture and pre ven ts normal fu ncti on of macro-
mol ec ule s. The pre sen ce s of avonoi ds are ab le to prote ct the se mole -fl
cul es from MG me di ate d modi cati on i nto AG Es. Gl utathi one i s a majorfi
consti tue nt of th e g lyoxalase path way, and one of th e most important
e ndog e nous anti oxidants for ne utral izati on of di carbonyl compoun ds
and mai ntai nin g re dox balance in ce lls . Fl avonoi d treatment was[26]
found to inc rease G SH conc entration, and i ncre ase d mRNA trans cript
le vel s of b oth G SH c ons titue nt sub uni ts . G SH is al so an e sse nti al[4, 26]
sub strate of astrocytic de toxi cation i n th e b rai n G SH i s als ofi [47] .
cri tic al f or preve nti on of g lutamate medi ate d apoptosi s . Ele vate d[115]
le vel s of g l utamate are c ytotoxic , and l ead to apoptosi s vi a i n ux offl
Ca . Exce ss g lutamate de pl ete s G SH , le adi ng to a de crease i n activi ty
of g lo 1 F lavon oi ds have sh own to reduc e intrace llu lar C a[ 25]. i n-
flu x in th e pre se nce of toxi c l eve ls of gl utamate [25] .
F lavonoid mol ecu le s c an reg ul ate s ig nali ng path ways to modulate
ce llu lar, i mmu ne , and me tab oli c proce sse s F lavonoids are ab le to[ 4] .
modu late a vari e ty of path ways inc ludi ng NF- B , MA PK , ERK, and Nrf2κ
[ 116, 117] . F lavonoi d mole cule s can modul ate and re duc e e xpre ssi on of
proapoptotic and proin ammatory produc ts of g en es . ROSfl [ 118, 119]
are use d as s ig nali ng mole cu le s duri ng immune re sponse s, and the
pre se nce of anti oxidants can preve nt ROS me di ate d ph osphorylati on of
mol ec ule s and pathway targe ts, preve nti ng the i r activati on an d tran -
scri ption . F lavonoids can als o in hi bi t acti vati on of k in as es and[ 109]
phosph atase s that would contri bu te to apoptoti c ce ll death
[ 120, 121, 4] . Afte r a avonoi d i s oxi dize d b y a free radi cal, th e re sulti ngfl
qui none s are in vol ve d in si gnali ng pathways i nvolve d i n ce ll ular anti -
oxi dant and re pai r acti vi tie s ( ).F i g. 3
F lavonoids can have a di rect impact an d i n uen ce on th e[ 122] fl
func ti on of the gyl oxalase pathway. F lavonoids can bi nd and scaven ge
fre e radi cals, and also inc rease th e in trace ll ular le ve ls of GS H, whi l e
flavonoids are ab le to s caveng e fre e radi cals , i n physi olog ic al c on-
ce ntrati ons the y are not e ecti ve ly ab le to s caveng e f re e radic al s .ff [25]
Th e mos t e e cti ve form of ne uroprotec tion by avonoi ds i s preve nti ngff fl
formati on of f re e radi cals by modul ati on of ce ll si g nali ng path ways
[ 109, 123, 124] . F lavonoid an ti oxidant treatmen t can lower th e i n-
trac el lular le ve ls of fre e radical s and ROS, and als o en hance th e pe r-
formance of the g lyoxalase syste m b y modu latin g si gnali ng pathways
i nvol ved i n c el lul ar proli fe rati on and survi val, g lutathi one syn th e si s
and e xpre ssi on of anti oxidati ve protei ns [4, 10, 14,25,121].
Mori n i s a avonoi d th at h as sh own to have e e cti ve an ti - i n-fl ff
flammatory an d anti- tumor fu ncti on . Morin was ab le to bl ock the[ 118]
activati on of N F- B pathway b y ROS and i n ammatory cytok in es,κ fl
pre ve ntin g a si g nali ng casc ade resu lti ng i n ce ll de ath . Morin[121]
e xe rted i ts control ove r the s ig nali ng path way by i nhi bi ti ng TNF i n-
duce d N F- B activati on by i nhi b iti ng de gradation of I B , and mori nκ κ α
was al so ab le to inh i bi t TNF me diate d p65 nucl ear trans location
[ 120, 125] . Morin i nhi b ite d ph os ph orylation of Ak t i n a b reast cance r
ce ll li ne , pre ven ti ng me tas tase s an d tumor prol ife ration M ori n[ 116] .
was sh own to dec rease su rvi val of cance r ce lls , wh il e i ncreasi ng vi a-
bi li ty of n ormal e ndoth e li al c el ls Th e se c ompounds are i nvolve d[ 116] .
i n th e pA kt - NF - B si g nali ng pathways i n ne uron al cel ls to enh ance theκ
g lyoxalase e xpre ss ion [ 4] .
F lavonoids have sh own e ffe cti ve nes s in modu lation of g lyoxalase
path way and MG de toxi cati on. Our pre vi ou s re se arch h as s hownfi
treatment wi th c ate ch i n, mori n, and que rc eti n was ab le to atte nuate th e
e ec ts of M G toxi ci ty wh il e re tain in g ce ll ular func ti on. The avonoidsff fl
i ncre as ed gl o 1 acti vi ty and G S H c on cen trati on , wh i le re duci ng th e
conce ntrati on of M G [ 4, 126] .
W hi le a lack of avonoids does not caus e any di sease , Exog e nousfl
antioxi dants can i n ue nce ce ll ular h ealth and o e r prote cti on ag ai ns tfl ff
in ammatory and de g ene rative di se ase s. A c orre lati on e xi sts be twee nfl
flavonoid cons umpti on and l ow le ve ls of deme nti a and ne ural pa-
tholog y I ntak e of avonoi ds can h ave a prote cti ve e e ct on[ 127]. fl ff
ne ural c el ls i n many di se ase d states . S i lymari n and nari ngi n[ 127,128]
are avon oi ds th at have s hown e cacy i n protec ti on ag ain st e x-fl ffi
ci totoxic ity i n dopamin erg i c neu rons . Si lymarin prote cte d mi ce agai nst
1-me thyl- 4- ph e nylpyri di ni um (MPP+) indu ce d toxic ity b y atte nuatin g
produc ti on of i n ammatory cytok in es, and pre ve nted mitoch ondrialfl
dysfunc ti on . Narin gi n protec te d ne ural ce ll s from toxi ci ty medi -[ 127]
ate d by 6- Hydroxydopami ne (6-OH DA ), me di ate d by an i ncre as e i n
Nrf2 acti vati on . Mori n h as also s hown to mi tig ate th e damag e[ 127]
cause d b y i sch emi a and stroke b y downreg ul ati ng e xpre ssi on and re -
le as e of proi n ammatory cytok in es . A grape powder e xtract wasfl [ 118]
sh own to reduc e anxie ty- li ke be h avi or, depre ssi on, and memory i m-
pai rments cause d by e le vate d OS [129] .
8. Mechanistic interference
W he n unde r states of stre ss and cytotoxi ci ty, ce lls ini ti ate anti-
oxi dant de fen se me ch an isms. Nu cle ar factor eryth roi d 2-re late d factor 2
(Nrf2) ac ti vation l eads to th e transc ripti on of protei ns involve d i n
counte racti ng oxi dati ve damag e The Nrf2 pathway i s ac ti vated[56] .
duri ng el evated OS . U nsti mulate d Nrf2 i s b ou nd to Ke ap1 i n th e cyto-
pl as m, and su bse que ntly ub iqu iti nated and deg raded . U nde r[130]
state s of OS, ROS di srupt th e associ ation b etwe en K eap1 and Nrf2. Nrf2
is re le as ed from the c omple x, and tran slocates to the n ucle us to b i nd the
an ti oxidant re sponse e le me nt (ARE), le adin g to the producti on of an-
tioxi dant mole cu le s ( ) Ge ne products functi on i n an anti -[ 55]. F ig . 4
oxi dant, anti- i n ammatory, and neu roprotec ti ve f ash i on . Amongfl [ 119]
the products are g lo 1, h eme oxyge nase - 1 (HO- 1), g amma- g lutamyl -
cyste in e s ynthe tas e (G CS ), and g lu tath ione - S- trans ferase .
K eap 1 i s a ne gati ve re gu lator of Nrf2. Ke ap 1 and C ull in- 3 contai n
Nrf2 i n th e c ytoplasm of ce lls . Cul li n- 3 ub iq ui ti nate s N rf 2 and i t i s
trans ported to proteasome for deg radati on. H i gh le ve ls of OS and fre e
radi cals ph osphorylate targe ts on K eap 1 and C ul li n-3 and di srupt the
Ke ap1- Cu lli n- 3 deg radati on syste m. Nrf2 i s not deg raded, and b ui lds up
in th e c ytoplasm unti l i t i s trans located to th e n ucle us and b inds to ARE
[131] . Nrf2 i s c riti cal f or me di ati ng e xpre ss ion of prote cti ve ge ne s in
res ponse to MG i nduce d OS and toxi ci ty, an d Nrf2 e xpre ssi on has be e n
sh owe d to su ppre ss accumul ati on of A GE s Ne urons tre ate d wi th a[56] .
Nrf2 acti vator we re prote cte d from MG medi ated damag e [ 132] . The
Nrf2 si g nali ng pathway inc rease d i ntrace ll ular G S H l eve ls , and i n-
crease d th e gl yoxalase path way's de toxi cation of MG prote cting c el lsfi
from OS medi ated damag e . Ne uron c el ls tre ated wi th N- ace tyl[133]
se rotoni n sh owed e nhanc ed n ucle ar trans location of Nrf2 from th e c y-
toplasm . N rf2 acti vators h ave sh own b e ne ts in PD ani mal[134] fi
mode ls, Nrf2 e xpre ssi on pre vente d 1-me thyl -4- phe nyl 1,2,3, 6 te tra-
hydropyri di ne (MPTP) in du ce d toxi ci ty i n ce lls . Fl avonoi ds are[135]
ab le to i ndi re ctl y in duce Nrf2 e xpre ssi on b y acti vati on of ki nase path -
ways resu lti ng in ph osphorylati on of Nrf2 and i nduc ti on of depe nde nt
ge ne s Nrf2 als o provi ded a s tre ss -re sponsi ve de fe nse ag ai nst[ 56,136] .
AG Es and le ad to trans cripti onal control of g lyoxal ase an d a[ 56]
temporal dynami c reci procal reg ul ati on of N rf 2 and g lo 1 was obs erve d
duri ng dise ase deve lopme nt Mang if erri n also u pre g ulated gl o 1[ 137].
throug h acti vating Nrf2/ ARE s ig nali ng path way [138] .
F lavonoids are ab le to modulate proi n ammatory sig nali ng path-fl
ways to pre ve nt OS and apoptos is . Paraoxyg e nase -2 (PNO2) is an[ 139]
en zyme i nvolve d i n neu roprotec ti on b y pre ven ti ng OS medi ated da-
mag e i n mi toch ondri a. F lavonoi ds c an modu late th e JN K/ AP- 1
path way to in crease e xpre ss ion of PN O2 . F lavon oi ds are ab le to[ 111]
in hi bi t expre ssi on of T NF- b y modulati ng NF - B, i nduci ng e xpre ssi onα κ
of an ti oxi dant mole cu le s l ik e PNO2. PNO2 i s pri mari ly located in the
mi toch on dri a. PN O2 e xe rts its ne uroprotec ti on pri mari ly th roug h pro-
tecti ng agai nst mitoch ondrial me di ate d oxi dati ve stres s [ 112] .
F lavonoids can di rectl y scave ng e fre e radi cals , b ut the y h ave li mite d
ac ce ssi bi li ty to the brai n; anti oxi dant conce ntration i n th e brai n i s too
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low to h ave a si g ni c an t i mpact on dire ct scave ngi ng . F lavon oi ds e xertfi
the i r prote cti ve e ects by modu lati on of cel l s ig nali ng path ways andff
activati on of ce llul ar antioxi dan t de fe nse me ch ani sms F lavo-[ 112].
noi ds also in hi bi t A GE formation by pre ve nti ng formati on /pre se nce of
di carb onyl c ompounds, and also atte nuate damag e F lavonoids[ 118] .
were foun d to redu ce MG me di ated OS, an d e nhance th e g lyoxal as e
path way acti vi ty [ 126].
9. Conclusion
Th e gl yoxalase path way i s an i nte g ral part of the body's anti oxi dant
syste m. Dysre g ulation can h ave de le te ri ous an d catas troph ic e ven ts ,
le adi ng to h ig h le ve ls of OS , and al so ne urode g e nerati ve dis ease . Th i s
se emi ng ly i nnocu ou s pathway found i n all ce ll s of ou r body can b e
res ponsi b le for produ cti on and formati on of toxi c i nte rme di ari e s th at
al ter a ce ll's normal fu ncti on and le adin g to Alzh e ime r's di se ase ,
Parki ns on 's di se ase, A SD and Ag in g. F lavon oi ds were foun d to be
Fig. 3. Fl a v on oid a nt io x ida nt s po ss es s s ev era l di s-
t inc t o f c el l ul a r neu ro pro tec t io n. Fl a vo no ids r ed uc ed
t he a m ou nt of i n a m m a ti on a nd o x ida t iv e s tr ess infl
t he c ell u l a r en vi ron m ent t hro u gh m u l ti pl e m ea ns .
Fl a v on oid c om po un ds dir ec tl y s c a ven ge free ra dic a l s
a nd ROS , in c rea se int r ac el l u la r c on cen t ra t ion o f G SH
a nd an t iox id a nt m o l ec u l es, m odu l a t e NF - B si g-κ
na l in g pa thw a y s t o r edu ce a pop t os is, a nd redu c e
gl u t a ma t e m edia t ed Ca i nt ra c el l ul a r in u x. Thes efl
a ct io ns o f av o noi ds di rec tl y en ha nc e t he g l yo x al a s efl
pa t hwa y .
Fig. 4. In a ct i ve N rf2 is bou nd t o Kea p1 an d Cu l l in-3
in t he c yt o pl a sm . Cu l li n-3 u biq uit in a t es N rf2 a n d is
t ar get ed fo r p rot eo so ma l d egr ad a ti on . El ev a t ed l e-
v els o f elec t ro phil es a nd ROS dis ru pt the abi li ty o f
Cu l li n-3 t o deg ra de N rf 2. N rf2 buil d s u p in t he c y-
t opl a s m, a n d tr a ns l oc a tes t o t he n uc l eu s. I t for m s a
c om pl ex w it h Ma f a n d bin ds t o A RE , in du c ing t he
t ra ns c ript io n of a n t iox id an t d efens e mo l ecu l es t o
pro t ect t he cel l fr om cy t o to x ic it y .
J.R. Frandsen, P. Narayanasamy Redox Biology 14 (2018) 465–473
470
i nvol ved i n th e re ducti on of oxi dative s tre ss th roug h me ch anis ms
reg ul ate d by th e g lyoxal as e pathway. F lavonoi d compounds h ave
sh own th e ab il ity to scave ng e ROS and reg ul ate ce ll si g nali ng pathways
i nteg ral for anti oxidant de fe nse me ch an is ms and ce llu lar s urvival. Th e
g lyoxalase pathway i s a promis in g dru g targ et for ne urode g e nerati ve
di sease s. Dru g dis covery and del ive ry pro-[ 4,140 144]– [ 145 147]–
ce sse s could be e xpl ore d i n thi s targ et ag ai nst ne urode ge ne rati ve di s-
e as es. Nove l avonoi ds could b e de si gn ed, synth es ize d, and tes te d tofl
prote ct ne urodeg e ne rati ve dis ease s throug h gl yoxalase pathway.
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